全文获取类型
收费全文 | 14613篇 |
免费 | 1726篇 |
国内免费 | 889篇 |
学科分类
工业技术 | 17228篇 |
出版年
2024年 | 29篇 |
2023年 | 240篇 |
2022年 | 464篇 |
2021年 | 649篇 |
2020年 | 516篇 |
2019年 | 412篇 |
2018年 | 465篇 |
2017年 | 509篇 |
2016年 | 518篇 |
2015年 | 613篇 |
2014年 | 766篇 |
2013年 | 1068篇 |
2012年 | 1102篇 |
2011年 | 1141篇 |
2010年 | 1031篇 |
2009年 | 998篇 |
2008年 | 1014篇 |
2007年 | 971篇 |
2006年 | 941篇 |
2005年 | 753篇 |
2004年 | 512篇 |
2003年 | 441篇 |
2002年 | 372篇 |
2001年 | 302篇 |
2000年 | 273篇 |
1999年 | 183篇 |
1998年 | 150篇 |
1997年 | 126篇 |
1996年 | 103篇 |
1995年 | 88篇 |
1994年 | 79篇 |
1993年 | 73篇 |
1992年 | 34篇 |
1991年 | 55篇 |
1990年 | 29篇 |
1989年 | 22篇 |
1988年 | 26篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 14篇 |
1984年 | 20篇 |
1983年 | 7篇 |
1982年 | 13篇 |
1981年 | 15篇 |
1980年 | 12篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1973年 | 6篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
2.
3.
Rikako Tabata SungGi Chi Junichiro Yuda Yosuke Minami 《International journal of molecular sciences》2021,22(4)
Several immune checkpoint molecules and immune targets in leukemic cells have been investigated. Recent studies have suggested the potential clinical benefits of immuno-oncology (IO) therapy against acute myeloid leukemia (AML), especially targeting CD33, CD123, and CLL-1, as well as immune checkpoint inhibitors (e.g., anti-PD (programmed cell death)-1 and anti-CTLA4 (cytotoxic T-lymphocyte-associated protein 4) antibodies) with or without conventional chemotherapy. Early-phase clinical trials of chimeric antigen receptor (CAR)-T or natural killer (NK) cells for relapsed/refractory AML showed complete remission (CR) or marked reduction of marrow blasts in a few enrolled patients. Bi-/tri-specific antibodies (e.g., bispecific T-cell engager (BiTE) and dual-affinity retargeting (DART)) exhibited 11–67% CR rates with 13–78% risk of cytokine-releasing syndrome (CRS). Conventional chemotherapy in combination with anti-PD-1/anti-CTLA4 antibody for relapsed/refractory AML showed 10–36% CR rates with 7–24 month-long median survival. The current advantages of IO therapy in the field of AML are summarized herein. However, although cancer vaccination should be included in the concept of IO therapy, it is not mentioned in this review because of the paucity of relevant evidence. 相似文献
4.
介绍了解的适定性、Carleman估计、可观测性不等式和最优控制概念,通过推导证明存在一个控制函数,使原方程的解在t=T时为零,说明此方程具有零可控性. 相似文献
5.
6.
7.
8.
World Wide Web - To solve the problem that users’ retrieval intentions are seldom considered by personalized websites, we propose an improved incremental collaborative filtering (CF)-based... 相似文献
9.
10.
Anastasia A. Ivanova Chi Phan Ahmed Barifcani Stefan Iglauer Alexey N. Cheremisin 《Journal of surfactants and detergents》2020,23(2):327-338
Surfactant flooding has widely been used as one of the chemically enhanced oil recovery (EOR) techniques. Surfactants majorly influence the interfacial tension, γ, between oil and brine phase and control capillary number and relative permeability behavior and, thus, influence ultimate recovery. Additives, such as nanoparticles, are known to affect surfactant properties and are regarded as promising EOR agents. However, their detailed interactions with surfactants are not well understood. Thus, in this work, we examined the influence of silica nanoparticles on the ability of surfactants to lower γ and to increase viscosity at various temperatures and salinities. Results show that the presence of nanoparticles decreased γ between n-decane and various surfactant formulations by up to 20%. It was found that γ of nanoparticles–surfactant solutions passed through a minimum at 35 °C when salt was added. Furthermore, the viscosity of cationic surfactant solutions increased at specific salt (1.5 wt.%) and nanoparticle (0.05 wt.%) concentrations. Results illustrate that selected nanoparticles–surfactant formulations appear very promising for EOR as they can lower brine/n-decane interfacial tension and act as viscosity modifiers of the injected fluids. 相似文献